These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 20149329)
1. Methotrexate bioavailability after oral and subcutaneous dministration in children with juvenile idiopathic arthritis. Tuková J; Chládek J; Nemcová D; Chládková J; Dolezalová P Clin Exp Rheumatol; 2009; 27(6):1047-53. PubMed ID: 20149329 [TBL] [Abstract][Full Text] [Related]
2. Bioavailability of higher dose methotrexate comparing oral and subcutaneous administration in patients with rheumatoid arthritis. Hoekstra M; Haagsma C; Neef C; Proost J; Knuif A; van de Laar M J Rheumatol; 2004 Apr; 31(4):645-8. PubMed ID: 15088287 [TBL] [Abstract][Full Text] [Related]
3. Subcutaneous administration of methotrexate with a prefilled autoinjector pen results in a higher relative bioavailability compared with oral administration of methotrexate. Pichlmeier U; Heuer KU Clin Exp Rheumatol; 2014; 32(4):563-71. PubMed ID: 24983446 [TBL] [Abstract][Full Text] [Related]
4. Splitting high-dose oral methotrexate improves bioavailability: a pharmacokinetic study in patients with rheumatoid arthritis. Hoekstra M; Haagsma C; Neef C; Proost J; Knuif A; van de Laar M J Rheumatol; 2006 Mar; 33(3):481-5. PubMed ID: 16463431 [TBL] [Abstract][Full Text] [Related]
5. Methotrexate efficacy, but not its intolerance, is associated with the dose and route of administration. Fráňová J; Fingerhutová Š; Kobrová K; Srp R; Němcová D; Hoza J; Uher M; Saifridová M; Linková L; Doležalová P Pediatr Rheumatol Online J; 2016 Jun; 14(1):36. PubMed ID: 27301536 [TBL] [Abstract][Full Text] [Related]
6. The role of subcutaneous administration of methotrexate in children with juvenile idiopathic arthritis who have failed oral methotrexate. Alsufyani K; Ortiz-Alvarez O; Cabral DA; Tucker LB; Petty RE; Malleson PN J Rheumatol; 2004 Jan; 31(1):179-82. PubMed ID: 14705239 [TBL] [Abstract][Full Text] [Related]
7. Methotrexate intolerance in oral and subcutaneous administration in patients with juvenile idiopathic arthritis: a cross-sectional, observational study. van Dijkhuizen EH; Pouw JN; Scheuern A; Hügle B; Hardt S; Ganser G; Kümmerle-Deschner JB; Horneff G; Holzinger D; Bulatović Ćalasan M; Wulffraat NM Clin Exp Rheumatol; 2016; 34(1):148-54. PubMed ID: 26843067 [TBL] [Abstract][Full Text] [Related]
8. Head-to-head, randomised, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis: drug-exposure limitations of oral methotrexate at doses ≥15 mg may be overcome with subcutaneous administration. Schiff MH; Jaffe JS; Freundlich B Ann Rheum Dis; 2014 Aug; 73(8):1549-51. PubMed ID: 24728329 [TBL] [Abstract][Full Text] [Related]
9. Why intramuscular methotrexate may be more efficacious than oral dosing in patients with rheumatoid arthritis. Hamilton RA; Kremer JM Br J Rheumatol; 1997 Jan; 36(1):86-90. PubMed ID: 9117183 [TBL] [Abstract][Full Text] [Related]
10. Influence of food on the bioavailability of oral methotrexate in children. Dupuis LL; Koren G; Silverman ED; Laxer RM J Rheumatol; 1995 Aug; 22(8):1570-3. PubMed ID: 7473485 [TBL] [Abstract][Full Text] [Related]
11. Analysis of intracellular methotrexate polyglutamates in patients with juvenile idiopathic arthritis: effect of route of administration on variability in intracellular methotrexate polyglutamate concentrations. Becker ML; van Haandel L; Gaedigk R; Lasky A; Hoeltzel M; Stobaugh J; Leeder JS Arthritis Rheum; 2010 Jun; 62(6):1803-12. PubMed ID: 20191581 [TBL] [Abstract][Full Text] [Related]
12. Combination therapy with methotrexate and hydroxychloroquine for rheumatoid arthritis increases exposure to methotrexate. Carmichael SJ; Beal J; Day RO; Tett SE J Rheumatol; 2002 Oct; 29(10):2077-83. PubMed ID: 12375315 [TBL] [Abstract][Full Text] [Related]
13. Prefilled pen versus prefilled syringe: a pilot study evaluating two different methods of methotrexate subcutaneous injection in patients with JIA. Roszkiewicz J; Swacha Z; Smolewska E Pediatr Rheumatol Online J; 2020 Aug; 18(1):64. PubMed ID: 32787934 [TBL] [Abstract][Full Text] [Related]
14. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate. Ruperto N; Murray KJ; Gerloni V; Wulffraat N; de Oliveira SK; Falcini F; Dolezalova P; Alessio M; Burgos-Vargas R; Corona F; Vesely R; Foster H; Davidson J; Zulian F; Asplin L; Baildam E; Consuegra JG; Ozdogan H; Saurenmann R; Joos R; Pistorio A; Woo P; Martini A; Arthritis Rheum; 2004 Jul; 50(7):2191-201. PubMed ID: 15248217 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic profile of methotrexate in psoriatic skin via the oral or subcutaneous route using dermal microdialysis showing higher methotrexate bioavailability in psoriasis plaques than in non-lesional skin. Quist SR; Quist J; Birkenmaier J; Stauch T; Gollnick HP J Eur Acad Dermatol Venereol; 2016 Sep; 30(9):1537-43. PubMed ID: 27005005 [TBL] [Abstract][Full Text] [Related]
16. Oral to subcutaneous methotrexate dose-conversion strategy in the treatment of rheumatoid arthritis. Schiff MH; Sadowski P Rheumatol Int; 2017 Feb; 37(2):213-218. PubMed ID: 28012023 [TBL] [Abstract][Full Text] [Related]
17. Methotrexate and Rheumatoid Arthritis: Current Evidence Regarding Subcutaneous Versus Oral Routes of Administration. Bianchi G; Caporali R; Todoerti M; Mattana P Adv Ther; 2016 Mar; 33(3):369-78. PubMed ID: 26846283 [TBL] [Abstract][Full Text] [Related]